Intellegens

Optibrium, Intellegens and Medicines Discovery Catapult have announced that they have been awarded a £1 million grant from Innovate UK to support the development of artificical Intelligence (AI) in drug discovery

Intellegens, a new company spun out of the University of Cambridge to develop and commercialise novel artificial intelligence (AI) software, has received funding from Cambridge Enterprise and local angel investor Graham Snudden